Current Issue Previous Issues Subscribe for FREE
Who’s Who in Health Care

by Michelle Boyles

Philadelphia has long maintained a reputation as a premier provider of top medical care. This month, we shine a spotlight on the nurses, doctors, administrators, researchers and more who are the driving force behind enhancing the scope of medicine and improving care for those who live and work here


Madeline Bell, president and CEO, Children’s Hospital of Philadelphia
Bell oversees 13,500 employees for the $2.5 billion-a-year health system and research institute. Prior to being promoted to CEO in July of 2015, Bell served as the CHOP chief operating officer for eight years. During her tenure as COO, she led significant growth while maintaining the financial strength and clinical excellence of the organization.

As a nurse, Bell began her career in pediatrics and moved from a variety of different nursing roles into hospital administration in 1989. During her time at CHOP, she has led the development of the ambulatory network, including home care, physician practice acquisition and community hospital partnerships.

What drew you to the health care field?
I entered the health care field as a nurse and expected to spend my career caring for patients, but I began to grow curious about the health care system. Ultimately, I wanted to influence the health care field as a leader.


Anthony Coletta, M.D., MBA, president, Independence Blue Cross Facilitated Health Network and executive vice president of Independence
Coletta, became president of Independence’s Facilitated Health Networks earlier this year and continues to serve as executive vice president of Independence. This new position leading Facilitated Health Networks demonstrates Independence’s commitment to drive improvements in health care quality and costs for its members across southeastern Pennsylvania. In this role, Coletta leads the development of Independence’s strategic relationships with physicians and health systems, innovative provider contracts, and sophisticated informatics and predictive analytics capabilities.

What’s the most significant change to the industry you’ve seen in the course of your career?
Among the major changes in health care, such as the Affordable Care Act, the gradual decline in the critically important doctor-patient relationship is one that has had a profound effect on both the quality and cost of health care. Great care starts with a trusting relationship between the primary care physician and the patient.


Charlene Compher, Ph.D., president, the American Society for Parenteral and Enteral Nutrition
Compher is professor of nutrition science at the University of Pennsylvania School of Nursing and has been a member of the faculty there since 2001. An international authority on nutritional care of patients with severe gastrointestinal disease, she has worked with the Clinical Nutrition Support Service at the Hospital of the University of Pennsylvania since 1987. In June, she became president of the American Society for Parenteral and Enteral Nutrition, a national organization of multi-disciplinary healthcare professionals dedicated to improving the science and practice of nutrition support and metabolism.

What drew you to the health care field?
My passion for understanding the scientific underpinnings of nutrition-related diseases and states of health drew me to nutrition science. The ability to use that knowledge for good in a clinical setting brought me to the Clinical Nutrition Support Service at the Hospital of the University of Pennsylvania and to the American Society for Parenteral and Enteral Nutrition.


Verdi J. DiSesa, M.D., MBA, president and CEO, Temple University Hospital
DiSesa became president and CEO of Temple University Hospital (TUH) upon the departure of John N. Kastanis on March 1. As DiSesa assumed his new role at TUH, he maintained his duties as chief operating officer of Temple University Health System and senior vice dean for clinical affairs in the Lewis Katz School of Medicine at Temple University, as he continues to oversee the strategic direction of quality, safe and cost-effective clinical services of the Health System and support comprehensive education and training of the next generation of physicians.

What drew you to the health care field?
I went into medicine because I wanted to use whatever talents and skills I might possess to make a positive contribution in the lives of patients. I have that same objective now as a health care administrator and executive, roles in which I can contribute to the lives not only of many patients but also of the physician, nursing, and other professional colleagues with whom I work every day.


Henry C. Fung, M.D., FRCPE, vice chair of Hematology at Fox Chase and director of the Fox Chase-Temple BMT Program
Fung is also the director of Fox Chase-Temple Bone Marrow Transplant Program and a professor of hematology/oncology. Previously, he had held faculty and leadership positions at City of Hope National Medical Center, UC Irvine and Rush University. Fung’s clinical practice and research focused on the treatment of lymphomas, myeloma and acute leukemia, in particular, related to the use of stem cell transplantation for these life-threatening hematologic disorders. Over the past two decades, Fung has authored and coauthored over 200 peer reviewed scientific articles and abstracts in high impact peer review journals such as Blood, British Journal of Hematology and Journal of Clinical Oncology.

What’s the most significant change to the industry you’ve seen in the course of your career?
Better understanding of the disease has led to better treatment and potential cure for many life threatening diseases which were incurable in the past. For example, it was thought that cancer was a single disease not too long ago, but in fact this constitutes thousands of different diseases and every patient is a unique person. Precision medicine is becoming a reality, specifically cancer medicine, and is the future of medicine.


Anita Gupta, D.O., PharmD, vice chair and associate professor at Drexel University College of Medicine in the division of pain medicine in the department of anesthesiology
Gupta is a board-certified anesthesiologist, pain specialist, pharmacist and an author of top-selling books including, Interventional Pain Medicine and Pharmacology in Anesthesia Practice. As a recognized, international authority on pain medicine, Gupta has served as an influential medical expert for CNN, Forbes, Fox News, NBC, The Examiner, Parade, and many more for stories related to a broad range of breaking medical news and in particular on the opioid epidemic.

What’s your favorite way to spend off hours?
My family comes first and making time to spend with them is my priority. Everything I do at work, community and home is driven on ensuring that I am leaving a legacy of a better world for them and their communities.


Lisa Jablon, M.D., FACS, director, the Breast Program at Einstein Medical Center
Under Jablon’s leadership, Einstein’s Breast Health Program received national recognition as an Accredited Breast Center by the American College of Surgeons. Jablon also serves as the director of the Genetics Risk Program and helps counsel women who have family histories of breast and ovarian cancer. She received the Light of Life Award from Susan G. Komen for the Cure Philadelphia in 2012.

What drew you to the health care field?
My father was a physician and both my parents were very encouraging about the field. I was always fascinated by anatomy and the workings of the human body. Surgery was just an easy fit.


Stephen Klasko, M.D., MBA, president and CEO, Thomas Jefferson University and Jefferson Health
As the President and CEO of Philadelphia-based Thomas Jefferson University and Jefferson Health, Klasko is bridging the art and science of medicine and health care transformation. He has championed transformation of American health care as university president, dean of two medical colleges and CEO of three academic health centers.

Since 2014, Jefferson Health has grown from a three hospital urban academic medical center with annual revenues of $1.8 billion to a major regional academic medical center.

What’s the most significant change to the industry you’ve seen in the course of your career?
The loss of fun and collegiality that had previously existed across practices, medical centers and hospitals. … We have become more competitive and fragmented at a time where Philadelphia and other communities would be well served to create a more team-based approach across health care entities to disrupt health care.


Jack Lynch, president and CEO, Main Line Health
During his tenure with Main Line Health, Lynch and his leadership team have been credited with strengthening the organization’s commitment to patient quality and safety and enhancing the technology necessary to support significant advances in those areas. He has also fostered a period of expansion, including the addition of an acute care hospital and two health centers to better serve the needs of the Main Line and western suburban communities.

What drew you to the health care field?
My father was a physician, and my mother was a nurse. Their passion for their patients and the advancement of medicine and the delivery of equitable care was an inspiration to me and many others. While I knew I did not want to be a clinician, I did know that I wanted to pursue a career in health care. And like my father, reducing disparities in health care has since become my passion.


Brendan McCorkle, founder and CEO, CloudMine
McCorkle is the CEO of CloudMine, where he oversees management practices and drives the company’s high-level strategic vision. He is a serial entrepreneur with a background in health care delivery as well as extensive mobile and UX experience. Prior to CloudMine, Brendan founded three companies, two of them software and mobile related.

What’s the most significant change to the industry you’ve seen in the course of your career?
The most significant change that I’ve seen would surely be mass adoption of mobile computing. At first, it led to improved access to health tech tools in the field. Now, however, it’s capturing massive amounts of contextual data, which is then coupled with big data analytics and machine learning. This data is at the core of improving quality of care and efficiency while decreasing costs and readmissions.


Owen Montgomery, M.D., chair of the OB-GYN department in the Drexel University College of Medicine
Montgomery is a specialist in general obstetrics and gynecology with special certification in the care of women in their post-reproductive years, including female pelvic reconstructive surgery and hormone therapy. Montgomery works nationally and internationally to improve the quality of care provided to pregnant women, especially the underserved, to reduce maternal mortality and to prevent sexual assault. He has also contributed to the development of smart fabric technologies, such as a “belly band” that wirelessly monitors pregnant mothers and babies.

What’s your favorite way to spend off hours?
We still work a lot of hours in OB-GYN, but we enjoy being off as well. Family comes first is our department motto, so when I am off I love to spend time with my wife, who works just as hard as I do, and our six (adult) children. Work hard and play hard.


Ralph W. Muller, president and CEO, University of Pennsylvania Health System
Prior to joining UPHS, Muller served as the president and CEO of the University of Chicago Hospitals and Health System. In 2001-2002, he was a Visiting Fellow at the Kings Fund in London, U.K. He also served as the deputy dean of the division of the biological sciences at the Pritzker School of Medicine at the University of Chicago. Previously, he had been budget director at the University.

What drew you to the health care field?
Running the department of Medicaid in Massachusetts in the mid-1970s.


Wolfgang Oster, M.D., PhD., CEO and chairman, Oncoceutics
Oster has had successful careers in academia, in the pharma/biotech corporate world and in the investment industry. He received board certifications for internal medicine, hematology, and oncology, and served as adjunct professor at the Brown Medical School and at the University of Freiburg, Germany. At US BioScience he was instrumental as chief medical officer in the successful merger with Medimmune. At PolyTechnos he built a life science portfolio leading to five U.S. and European IPOs.

What’s your favorite way to spend off hours?
One of the challenges in this field is to develop a bold vision without becoming unrealistic. This requires inspiration, which often arises from personal experiences, accompanied by recognition of limitations. I greatly enjoy looking at problems from different cultural perspectives and learning how limitations could be overcome.


Tim Petrikin, CEO, Ampersand Health
Petrikin and former colleagues at Vanguard Health Systems and e+CancerCare co-founded Ampersand Health shortly after Tenet Healthcare’s acquisition of Vanguard. Ampersand Health is developing markets, opening clinics and implementing proprietary workflows through investment in the most powerful and efficient mechanism for improving health and reducing costs–primary care.

What drew you to the health care field?
I was selling saddles in Nashville, Tenn. 20 years ago when my youngest son was born and I needed to get a “real” job. Health care was and remains a leading industry in Nashville, alongside music, of course. Since then, I’ve been consistently drawn by the idea of doing good while doing well. Makes every day really easy to come to “work."


Mason Reiner, co-founder and CEO, R-Health
R-Health is a leader in innovative health care solutions that is dedicated to delivering more effective primary care and a better patient experience, while reducing the overall cost of health care. Reiner is a founding member of the Steering Committee of the National Direct Primary Care Coalition, the leading industry organization advancing the direct primary care model around the country, and is a sought-after speaker on various aspects of the direct primary care model.

What drew you to the health care field?
A large, fragmented industry that is going through a tremendous amount of change, and where you can make a major positive impact on people’s lives, is an entrepreneur’s dream.


Katherine Schneider, M.D., president and CEO, Delaware Valley Accountable Care Organization
Nationally known for her work in the field of accountable care and patient engagement, Schneider's mission is to deliver better health, better care and sustainable cost in the communities that we work in, live in and serve.

Schneider provides leadership, strategic direction and ongoing administration and management for all aspects of the Delaware Valley Accountable Care Organization, the Philadelphia region’s largest accountable care organization.

What’s the most significant change to the industry you’ve seen in the course of your career?
The move from paying for volume and fee-for-service to paying for value and outcomes has truly accelerated over the past 10 years. This shift has been supported by a better understanding of the use of data and technological advancements in health care. Also, innovation (e.g. genomics, proteomics, robotics) is revolutionizing medicine at an unbelievable pace, but we have to figure out how to pay for all this in a way that does not take over our entire economy.

Published (and copyrighted) in Philly Biz, Volume 1, Issue 7 (June, 2016).
For more info on Philly Biz magazine, click here.
To subscribe to Philly Biz magazine, click here.
To advertise in Philly Biz magazine, call 856-797-9901.